Cerebrolysin

Q: What is the typical dosage for Cerebrolysin?

The typical dosage is 5–30 mL (IM/IV), administered via Intramuscular or intravenous injection.

Q: What is the half-life of Cerebrolysin?

The half-life of Cerebrolysin is ~2–4 hours.

Q: Is Cerebrolysin FDA approved?

No, Cerebrolysin is currently classified as "Clinical Trials" and is not FDA approved for general use.

Also known as: FPE 1070

A concentrated neuropeptide mixture derived from porcine brain tissue, approved in 40+ countries for stroke recovery, TBI, and dementia. Forces actual physical neurogenesis.

Reviewed by Dr. Sarah Mitchell, PharmD, BCPS

Lead Researcher · 12+ years in peptide therapeutics

Half-Life

~2–4 hours

Typical Dose

5–30 mL (IM/IV)

Administration

Intramuscular or intravenous injection

Mechanism of Action

Provides a cocktail of neurotrophic peptides that mimic BDNF, NGF, and CNTF, promoting neurite outgrowth, synaptogenesis, and neuronal survival.

Key Research Areas

neuroprotectivestrokeTBIdementianeurogenesis

Frequently Asked Questions

What is Cerebrolysin?▾

A concentrated neuropeptide mixture derived from porcine brain tissue, approved in 40+ countries for stroke recovery, TBI, and dementia. Forces actual physical neurogenesis.

How does Cerebrolysin work?▾

Provides a cocktail of neurotrophic peptides that mimic BDNF, NGF, and CNTF, promoting neurite outgrowth, synaptogenesis, and neuronal survival.

What is the recommended dosage for Cerebrolysin?▾

The typical research dosage is 5–30 mL (IM/IV), administered via Intramuscular or intravenous injection. Dosage protocols vary by study and should be determined by a qualified healthcare professional.

What is the half-life of Cerebrolysin?▾

The half-life of Cerebrolysin is approximately ~2–4 hours. This affects dosing frequency and timing in research protocols.

Is Cerebrolysin FDA approved?▾

Cerebrolysin is currently classified as "Clinical Trials" and is not FDA approved for general use. It is available for research purposes or through compounding pharmacies depending on your jurisdiction.

Research Disclaimer

The information provided about Cerebrolysin is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.

Related Peptides in Neuroprotective

ARA-290

Cibinetide

Cortexin

Brain Peptide Complex

Kyotorphin

L-Tyrosyl-L-Arginine · Tyr-Arg

Back to All Peptides Find Your Peptide — Take the Quiz